Description

ABP-7 (Actin Binding Peptide-7)

ABP-7, or Actin Binding Peptide-7, is a heptapeptide composed of seven amino acids with the sequence Acetyl-LKKTETQ. It represents an N-acylated fragment (residues 17–23) of the larger molecule Thymosin Beta-4, and for this reason, it is sometimes referred to as the **TB-500 Fragment**.

ABP-7 is a synthetic peptide produced through solid-phase peptide synthesis. The LKKTETQ sequence is considered the central actin-binding domain of Thymosin Beta-4, suggesting that ABP-7 may share similar actin-binding properties with its parent molecule. Thymosin Beta-4 functions as an actin-binding protein primarily through this domain, which inhibits the polymerization of globular actin (G-actin) into filamentous actin (F-actin), a process known as actin sequestration. This inhibition can lead to elevated levels of G-actin within cells.

Actin, a major component of the cellular cytoskeleton, is essential for maintaining structural integrity and enabling cell movement and shape change. ABP-7 may stabilize actin in its monomeric form, reducing its ability to polymerize into F-actin. This potential modulation of the cytoskeleton could affect cell motility, shape adaptation, and other actin-dependent functions such as intracellular transport and signal transduction. Because cell migration plays a critical role in tissue repair, the peptide’s influence on actin dynamics may have implications for wound healing and tissue regeneration.

—

**Chemical Makeup**

Molecular Formula: C38H81N9O20
Molecular Weight: 889.5 g/mol
Other Known Titles: TB-500 Fragment, Ac-LKKTETQ

—

**Research and Clinical Studies**

**ABP-7 and Wound Healing**

In a study examining the actin-binding domain of Thymosin Beta-4, ABP-7 was evaluated for its potential to enhance wound repair in aged murine models. The research assessed keratinocyte migration, collagen deposition, and wound closure rates. The study concluded that the seven-amino-acid peptide LKKTETQ promoted wound repair in aged mice comparably to the full Thymosin Beta-4 molecule.

It is suggested that ABP-7 promotes epidermal cell migration and collagen deposition at wound sites, facilitating faster closure and healing. Thymosin Beta-4 and its derived peptides, including ABP-7, have been studied for their ability to enhance keratinocyte migration—an essential process in wound recovery. By mimicking the functional domain of Thymosin Beta-4, ABP-7 may activate similar biological pathways that support tissue repair, though further research is needed to fully understand its mechanism and therapeutic potential.

Additional studies propose several possible mechanisms through which ABP-7 may accelerate wound healing. One hypothesis suggests the peptide interacts with purinergic receptors, which regulate cellular responses to injury. This interaction may elevate intracellular calcium levels, triggering pathways involved in cell migration and extracellular matrix remodeling—key processes in wound closure. Another proposed mechanism involves ABP-7’s interaction with actin, potentially stabilizing or altering the cytoskeletal structure to improve cell movement across wound sites. ABP-7 may also influence downstream signaling pathways, such as MAP kinase cascades, which regulate genes involved in cell proliferation and migration.

—

**ABP-7 and Tissue Scarring (Fibrosis)**

Research exploring the anti-fibrotic potential of ABP-7 has focused on its effects on hepatic stellate cells (HSCs) in liver fibrosis models. Preliminary data suggest that ABP-7 may inhibit PDGF-BB-dependent upregulation of biomarkers such as PDGFβ receptor, α-smooth muscle actin (α-SMA), and collagen type I. It may also block Akt phosphorylation at T308 and S473, which in turn could prevent phosphorylation of PRAS40—a key regulator of cell survival and metabolism.

By interfering with these signaling pathways, ABP-7 may disrupt processes crucial to HSC activation, proliferation, and migration—core drivers of fibrogenesis. These findings indicate that ABP-7 could potentially mitigate HSC activation and reduce fibrotic tissue development, suggesting a possible role in controlling or preventing fibrosis.

—

**ABP-7 and Angiogenesis**

ABP-7 may also influence angiogenesis, the formation of new blood vessels. It appears to promote endothelial cell migration and tube formation in vitro—two essential processes for angiogenesis. Ex vivo studies, such as aortic ring assays, have indicated that ABP-7 may enhance vessel sprouting, an early step in blood vessel formation.

Researchers propose that ABP-7’s actin-binding activity may alter actin availability within endothelial cells, facilitating the dynamic structural changes required for angiogenesis. By influencing cell shape, movement, and cytoskeletal organization, ABP-7 might create conditions favorable to vascular development. It is also possible that ABP-7 interacts with additional cellular pathways or signaling molecules that regulate angiogenesis, though these interactions remain under active investigation.

—

**Summary**

ABP-7 (Actin Binding Peptide-7) is a synthetic heptapeptide derived from the actin-binding region of Thymosin Beta-4. Through its interaction with actin and involvement in key cellular pathways, ABP-7 has been studied for its potential roles in:

* Promoting wound healing and tissue repair
* Reducing fibrosis and tissue scarring
* Supporting angiogenesis and vascular growth

While these findings are preliminary, ABP-7 may represent an important research tool for studying cellular dynamics, tissue regeneration, and fibrotic disease processes.